Hyloris Pharmaceuticals SA (FRA:52U)
Germany · Delayed Price · Currency is EUR 7.96
+0.50 (6.70%)
At close: Jan 23, 2026
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €223.44 million as of January 30, 2026. Its market cap has increased by 41.49% in one year.
Market Cap
223.44M
Enterprise Value
205.97M
Revenue
8.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
€7.96
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 223.44M, a decrease of -8.69%. That is a compound annual growth rate of -1.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 223.44M | 16.67% |
| Dec 31, 2025 | 191.52M | 4.59% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SIMONA Aktiengesellschaft | 300.00M |
| EUWAX Aktiengesellschaft | 267.80M |
| centrotherm international AG | 241.25M |
| STINAG Stuttgart Invest AG | 232.23M |
| Sino AG | 229.08M |
| ÜSTRA Hannoversche Verkehrsbetriebe Aktiengesellschaft | 208.56M |
| Allane SE | 204.05M |
| Eleving Group | 186.27M |